US 9290541
TCL1 peptides for immunotherapy
granted A61KA61K2239/48A61K38/08
Quick answer
US patent 9290541 (TCL1 peptides for immunotherapy) held by The Board of Regents of the University of Texas System expires Mon Mar 17 2036 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The Board of Regents of the University of Texas System
- Grant date
- Tue Mar 22 2016 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Mar 17 2036 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 18
- CPC classes
- A61K, A61K2239/48, A61K38/08, A61K38/10, A61K38/16